Related Experiment Video
Updated: Dec 18, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
An Optimal Control Framework for the Automated Design of Personalized Cancer Treatments
Fabrizio Angaroni1, Alex Graudenzi1,2, Marco Rossignolo3,4
1Department of Informatics, Systems and Communication, University of Milan-Bicocca, Milan, Italy.
Control Theory for Therapy Design (CT4TD) optimizes personalized cancer treatments using patient-specific pharmacokinetic/pharmacodynamic models. This computational strategy aims to improve therapeutic efficacy while minimizing toxicity, offering a new approach to cancer care.
Area of Science:
- Computational oncology
- Systems biology
- Control theory applications in medicine
Background:
- Personalized cancer treatment remains a challenge, necessitating advanced computational strategies.
- Control theory offers a robust framework for therapy design and optimization.
- Existing clinical practices often overlook individual physiological heterogeneity.
Purpose of the Study:
- Introduce the Control Theory for Therapy Design (CT4TD) framework for personalized cancer treatment.
- Develop optimized therapeutic strategies by integrating patient-specific pharmacokinetic (PK) and pharmacodynamic (PD) models.
- Adapt and adjust cancer therapies based on individual patient data and treatment responses.
Main Methods:
- Employing optimal control theory on patient-specific PK/PD models.
- Utilizing the dCRAB/RedCRAB optimization algorithm for scalability and efficiency.
- Developing personalized administration strategies to achieve target drug concentrations and minimize toxicity.
- Adjusting ongoing therapies using simplified cancer population dynamics models to control tumor burden.
Main Results:
- CT4TD enables optimized, personalized drug administration strategies at diagnosis.
- The framework allows for dynamic adjustment of therapies using longitudinal patient data.
- Demonstrated efficacy in a proof-of-principle application to Imatinib treatment for Chronic Myeloid Leukemia.
- Optimized strategies showed patient-specific diversification and improvements over standard regimens.
Conclusions:
- CT4TD provides a scalable and robust computational framework for personalized cancer therapy.
- The approach effectively integrates PK/PD modeling and control theory for optimized treatment outcomes.
- CT4TD has broad applicability across various cancer therapies and administration protocols.
- This framework represents a significant advancement in supporting clinical decision-making for personalized cancer treatment.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Cancer
Tumor Immunotherapy